Memoli Va
Impact in
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
-
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Neuroendocrine Tumor Research Advances 5
- Oncology 4
- Lung Cancer Research Studies 4
- Co-authors
- Gould Ve (3 shared papers)Zacharski Lr (2 shared papers)Walter Kisiel (2 shared papers)Faber Lp (2 shared papers)Marek Z. Wojtukiewicz (1 shared paper)
- Journals
- Acta Cytologica (1 paper)PubMed (7 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Memoli Va
8 papers receiving 344 citations
Peers
Comparison fields: 5 of 49
- Hematology 81
- Internal Medicine 21
- Neurology 84
- Oncology 142
- Epidemiology 162
Countries citing papers authored by Memoli Va
This map shows the geographic impact of Memoli Va's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Memoli Va with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Memoli Va more than expected).
Fields of papers citing papers by Memoli Va
This network shows the impact of papers produced by Memoli Va. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Memoli Va. The network helps show where Memoli Va may publish in the future.
Co-authors
The 5 scholars most cited alongside Memoli Va, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neuroendocrine cells and neuroendocrine neoplasms of the lung. | 1983 | 165 |
| 2 | Distribution of tissue factor pathway inhibitor in normal and malignant human tissues. | 1993 | 86 |
| 3 | Fibrinogen-fibrin transformation in situ in renal cell carcinoma. | 1990 | 42 |
| 4 | Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. | 1985 | 21 |
| 5 | The cytodiagnosis of well-differentiated neuroendocrine carcinoma. A distinct clinicopathologic entity. | 1987 | 21 |
| 6 | Nesidiodysplasia and nesidioblastosis of infancy: ultrastructural and immunohistochemical analysis of islet cell alterations with and without associated hyperinsulinaemic hypoglycaemia. | 1981 | 20 |
| 7 | The biological implications of bronchial tumors. | 1984 | 19 |
| 8 | Well-differentiated pulmonary neuroendocrine carcinoma metastatic to the endometrium: a case report. | 1996 | 4 |
About Memoli Va
Memoli Va is a scholar working on Epidemiology, Oncology, Neurology, Surgery and Hematology, having authored 8 papers that have together received 378 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (4 papers), Neuroblastoma Research and Treatments (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Renal cell carcinoma treatment (1 paper), Blood Coagulation and Thrombosis Mechanisms (1 paper) and Hemophilia Treatment and Research (1 paper). The work is most often cited by research in Hematology (81 citations), Internal Medicine (21 citations), Neurology (84 citations), Oncology (142 citations) and Epidemiology (162 citations). Memoli Va has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Gould Ve, Zacharski Lr, Walter Kisiel, Faber Lp and Marek Z. Wojtukiewicz. Their work appears in journals such as Acta Cytologica and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.